Inhaled diazeniumdiolates (NONOates) as selective pulmonary vasodilators

Bibliography

• MALIK AB, FEUSTEL PJ: Pulmonary circulation and lung fluid and solute exchange. In: Respiratory Medicine. 2nd edn. Murray J, Nadel JA (eds). W.B. Saunders Company, Sydney, Australia (1994):139–174.
   Google Scholar
• WANG NS. Anatomy. In: Pulmonary Pathology Dail DH, Hammar SP (eds). Springer-Verlag, New York, USA (1988):17–40.
   Google Scholar
• BARNES PJ, LIU SF: Regulation of vascular tone. Pharmaca Rev (1995) 47:87–131.
   PubMed Web of Science ®Google Scholar
• NAUSER TD, STITES SW: Diagnosis and treatment of pulmonary hypertension. Family Physician (2001) 63:1789–1798.
   PubMed Web of Science ®Google Scholar
• VIEILLARD-BARON A, SCHMITT JM, AUGARDE R et al.: Acute cor pulmonale in acute respiratory distress syndrome submitted to protective ventilation: incidence, clinical implications, and prognosis. Crit. Care Med (2001) 29:1551–1555.
   PubMed Web of Science ®Google Scholar
• PALEVSKY HI, FISHMAN AP: Chronic cor pulmonale. Etiology and management. "AMA (1990) 263:2347–2353.
   Google Scholar
• BRENT BN, BERGER HJ, MATTHAY RA, MAHLER D, PYTLIK L, ZARET BL: Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: a combined radionuclide-hemodynamic study. Jim. .1 Cardia. (1983) 51:1682–1689.
   Web of Science ®Google Scholar
• THEBAUD B, ARNAL JF, MERCIER JC,DINH-XUAN AT: Inhaled and exhaled nitric oxide. Cell. Ma. Life Sci. (1999) 55:1103–1112.
   PubMed Web of Science ®Google Scholar
• •A review that provides a clear concept for Spy.
   Google Scholar
• ZAPOL WM: Inhaled nitric oxide. Acta Anaesthesia Scand. Sapp]. (1996) 109:81–83.
   PubMedGoogle Scholar
• VAN HEERDEN PV, BARDEN A, MICHALOPOULOS N, BULSARA MK, ROBERTS BL: Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS. Chest (2000) 117:819–827.
   PubMed Web of Science ®Google Scholar
• GESSLERT, SCHMEHL T, HOEPER MM et al.: Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension. Respir J. (2001) 17(1):14–19.
   PubMed Web of Science ®Google Scholar
• FULLERTON DA, KIRSON LE, JONES SD, MCINTYRE RC: Adenosine is a selective pulmonary vasodilator in cardiac surgical patients. Chest (1996) 109:41–46.
   PubMed Web of Science ®Google Scholar
• GOND F, SHIRAISHI H, KIKUCHI Y et al.: Inhalation of nebulized nitroglycerin in dogs with experimental pulmonary hypertension induced by U46619. Pediam Int. (2000) 42:255–258.
   PubMed Web of Science ®Google Scholar
• MEADOW W, RUDINSKY B, BELL A, HIPPS R: Effects of nebulized nitroprusside on pulmonary and systemic hemodynamics during pulmonary hypertension in piglets. Pediatr. Res. (1998) 44(2):181–186.
   PubMed Web of Science ®Google Scholar
• ICHINOSE F, ERANE-GARCIA J, HROME J et al: Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension. Crit. Care Med. (2001) 29(5):1086–1087.
   PubMed Web of Science ®Google Scholar
• FUKUTO JM: Chemistry of nitric oxide: biologically relevant aspects. Adv. Pharmacol (1995) 34:1–15.
   PubMedGoogle Scholar
• STEUDEL W, HURFORD WE, ZAPOL WM: Inhaled nitric oxide: basic biology and clinical applications. Anesthesiology (1999) 91:1090–1121.
   PubMed Web of Science ®Google Scholar
• ••A thorough review of NO, from basicbiochemistry to clinical therapeutics.
   Google Scholar
• WEINBERGER B, HECK DE, LASKIN DL, LASKIN JD: Nitric oxide in the lung: therapeutic and cellular mechanisms of action. Pharmaca Ther. (1999) 84:401–411.
   PubMed Web of Science ®Google Scholar
• HIGENBOTTAM T, PEPKE-ZABA J, SCOTT J, WOOLMAN P, WALLWORK J: Inhaled 'endothelium derived-relaxing factor' (EDRF) in primary hypertension. Am. Rev Respir. Dis. (1988) 137:A107.
   Google Scholar
• ROSSAINT R, FALKE KJ, LAPEZ F, SLAMA K, PISON U, ZAPOL WM: Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl. J. Med. (1993) 328:399–405.
   PubMed Web of Science ®Google Scholar
• •First controlled trial on patients with ARDS using inhaled NO.
   Google Scholar
• ABMAN SH, GRIEBEL JL, PARKER DK et al.: Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J. Pediam (1994) 124:881–888.
   Web of Science ®Google Scholar
• CHRISTENSON J, LAVOIE A, O'CONNOR M, BHORADE S, POHLMAN A, HALL JB: The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide. Am. I Respir. Crit. Care Med (2000) 161:1443–1449.
   PubMed Web of Science ®Google Scholar
• CUTHBERTSON BH, DELLINGER P, DYAR 0 et al.: UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs. Intensive Care Med (1997) 23(12):1212–1218.
   Google Scholar
• KEEFER L, NIMS RW, DAVIES KM, WINK DA: NONOates (1-substituted Diazen-1-ium-1,2-diolates) as nitric oxide donors; convenient nitric oxide dosage forms. Methods Enzymol (1996) 268:281–293.
   PubMed Web of Science ®Google Scholar
• ••An excellent review of NONOates.
   Google Scholar
• FITZHUGH AL, KEEFER LK: Diazeniumdiolates: pro- and antioxidant applications of the NONOates'. Free Radic. Biol. Med. (2000) 28(10):1463–1469.
   PubMed Web of Science ®Google Scholar
• BRILLI RJ, KRAFTE-JACOBS B, SMITH DJ et al.: Intratracheal instillation of a novel NO/nucleophile adduct selectively reduces pulmonary hypertension. I Appl. Physia (1997) 83(6):1968–1975.
   PubMed Web of Science ®Google Scholar
• ADRIE C, ICHINOSE F, HOLZMANN A, KEEFER L, HURFORD WE, ZAPOL WM: Pulmonary vasodilation by nitric oxide gas and prodrug aerosols in acute pulmonary hypertension. J. Appl. Physia (1998) 84(2):435–441.
   Web of Science ®Google Scholar
• WARE LB, MATTHAY MA: The acute respiratory distress syndrome. N Engl. Med. (2000) 342(18):1334–1349.
   PubMed Web of Science ®Google Scholar
• •A comprehensive current review of ARDS.
   Google Scholar
• FULKERSON WJ, MACINTYRE N, STAMLERJ, CRAPO JD: Pathogenesis and treatment of the adult respiratory distress syndrome. Arch. Intern. Med. (1996) 156(1):29–38.
   PubMed Web of Science ®Google Scholar
• PISON U, SEEGER W, BUCHHORN R et al.: Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am. Rev Respir. Dis. (1989) 140(4):1033–1039.
   PubMed Web of Science ®Google Scholar
• JOLIN A, BJERTNAES L: Hypoxic pulmonary vasoconstriction in the adult respiratory distress syndrome. Acta Anaesthesia Scand. Sapp]. (1991) 95:40–52.
   PubMed Web of Science ®Google Scholar
• BHORADE S, CHRISTENSON J, O'CONNOR M, LAVOIE A, POHLMAN A, HALL J: Response to inhaled nitric oxide in patients with acute right heart syndrome. Am. J. Respir. Grit. Care Med. (1999) 157:571–579.
   Web of Science ®Google Scholar
• SCHUSTER DP, KOLLEF MH: Acute respiratory distress syndrome. In: Cardiopulmonary Critical Care. 3rd edn. Dantzker DR, Scharf SM (eds). W.B. Saunders Company, Sydney, Australia (1998):415–433.
   Google Scholar
• KOLLEF MH AND SCHUSTER DP: The acute respiratory distress syndrome. N Engl. Merl (1995) 332(1):27–37.
   PubMed Web of Science ®Google Scholar
• HART CM: Nitric oxide in adult lung disease. Chest (1999) 115(5):1407–1417.
   PubMed Web of Science ®Google Scholar
• TILTON RG, BROCK TA, DIXON AF: Therapeutic potential of endothelin receptor antagonists and nitric oxide donors in pulmonary hypertension. Expert Opin. Investig. Drugs (2001) 10(7):1291–1308.
   PubMed Web of Science ®Google Scholar
• JACOBS BR, BRILLI RJ, BALLARD ET, PASSERINI DJ, SMITH DJ: Aerosolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury. Am. I Respir. Grit. Care Merl (1998) 158:1536–1542.
   PubMed Web of Science ®Google Scholar
• BRILLI RJ, KRAFTE-JACOBS B, SMITH DJ, PASSERINI DJ, MOORE L, BALLARD ET: Aerosolization of novel nitric oxide donors selectively reduce pulmonary hypertension. Crit. Care Med. (1998) 26(8):1390–1396.
   PubMed Web of Science ®Google Scholar
• JACOBS BR, SMITH DJ, ZINGARELLI B, PASSERINI DJ, BALLARD ET, BRILLI RJ: Soluble nitric oxide donor and surfactant improve oxygenation and pulmonary hypertension in porcine lung injury. Nitric Oxide (2000) 4(4):412–422.
   PubMed Web of Science ®Google Scholar
• GREGORY TJ, LONGMORE WJ, MOXIEY MA et al.: Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest. (1991) 88:1976–1981.
   PubMed Web of Science ®Google Scholar
• LAM CE VAN HEERDEN PV, SVIRI S, ROBERTS BL, ILETT KF: The effects of inhalation of a novel nitric oxide donor, DETA/NO in a patient with severe hypoxaemia due to the acute respiratory distress syndrome. Anaesth. Intensive Care (2002): In press.
   Google Scholar
• •First human application of DETA/NO.
   Google Scholar
• STUART R: Primary pulmonary hypertension. In: Harrison's Prindple.c of Internal Medicine. Volume 2. Fauci AS, Braunwald E, Isselbacher KJ et al (eds). McGraw-Hill Company, Sydney, Australia (1998):1466–1468.
   Google Scholar
• BRIJ S, PEACOCK AJ: Pulmonary hypertension: its assessment and treatment. Thorax (1999) 54 (Suppl. 2):S28–32.
   Google Scholar
• MOORADIAN DL, HUTSELL TC, KEEFER LK: Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation M vitro. J. Cardiovasc. Pharmaca (1995) 25(4):674–678.
   PubMed Web of Science ®Google Scholar
• •A key reference for the studies in DETA/ NO.
   Google Scholar
• ROBERTS JDJ, ROBERTS CT, JONES RC, ZAPOL WM, BLOCH KD: Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. C irc. Res (1995) 76(2):215–222.
   PubMed Web of Science ®Google Scholar
• KOUYOUMDJIAN C, ADNOT S, LEVAME M et al.: Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. Clin. Invest. (1994) 94(2):578–584.
   Google Scholar
• ROBERTS JDJ, CHICHE JD, WEIMANN J et al.: Nitric oxide inhalation decreases pulmonary artery remodeling in the injured lungs of rat pups. Circ. Res. (2000) 87(2):140–145.
   PubMed Web of Science ®Google Scholar
• HAMPL V, TRISTANI-FIROUZI M, HUTSELL TC, ARCHER SL: Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertension. Cardiovasc. Res (1996) 31:55–62.
   PubMed Web of Science ®Google Scholar
• PEACOCK AJ. Primary pulmonary hypertension. Thorax (1999) 54(12):1107–1118.
   PubMed Web of Science ®Google Scholar
• D'ALONZO GE, BARST RJ, AYRES SM et al.: Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann. Intern. Med. (1991) 115(5):343–349.
   Google Scholar
• SALVI SS: Alphal-adrenergic hypothesis for pulmonary hypertension. Chest (1999) 115(6):1708–1719.
   PubMed Web of Science ®Google Scholar
• BARST RJ, RUBIN LJ, LONG WA et al: A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl. I Med. (1996) 334(5):296–302.
   PubMed Web of Science ®Google Scholar
• WILKENS H, GUTH A, KONIG J et al: Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation (2001) 104(11):1218–1222.
   PubMed Web of Science ®Google Scholar
• PEREZ-PENATE G, JULIA-SERDA G, PULID 0-DUQUE JM, GORRIZ-GOMEZ E, CABRERA-NAVARRO P: One-year continuous inhaled nitric oxide for primary pulmonary hypertension. Chest (2001) 119(3):970–973.
   PubMed Web of Science ®Google Scholar
• CHANNICK RN, NEWHARTJW, JOHNSON FW et al.: Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension. An ambulatory delivery system and initial clinical tests. Chest (1996) 109:1545–1549.
   Google Scholar
• RICCIARDI MJ, RUBENFIRE M: How to manage secondary pulmonary hypertension. Recognizing and treating cor pulmonale and chronic thromboembolism. Postgrad. Med. (1999) 105(2):183–190.
   Google Scholar
• KLINGER JR, HILL NS: Right ventricular dysfunction in chronic obstructive pulmonary disease. Evaluation and management. Chest (1991) 99 (3) : 7 1 5–7 23 .
   Google Scholar
• MACNEE W: Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part two. Am. .1. Respir. Grit. Care Med. (1994) 150(4):1158–1168.
   Google Scholar
• GERMANN P, ZIESCHE R, LEITNER C et al.: Addition of nitric oxide to oxygen improves cardiopulmonary function in patients with severe COPD. Chest (1998) 114(1):29–35.
   PubMed Web of Science ®Google Scholar
• COCKRILL BA, KACMAREK RM, FIFER MA et al: Comparison of the effects of nitric oxide, nitroprusside, and nifedipine on hemodynamics and right ventricular contractility in patients with chronic pulmonary hypertension. Chest (2001) 119(1):128–136.
   PubMed Web of Science ®Google Scholar
• BAIGORRI F, JOSEPH D, ARTIGAS A, BLANCH L: Inhaled nitric oxide does not improve cardiac or pulmonary function in patients with an exacerbation of chronic obstructive pulmonary disease. Crit. Care Med. (1999) 27(10):2153–2158.
   PubMed Web of Science ®Google Scholar
• BARBERA JA, ROGER N, ROCA Jet al.: Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet (1996) 347:436–440.
   Google Scholar
• CHICHE JD, DHAINAUT JF: Inhaled nitric oxide for right ventricular dysfunction in chronic obstructive pulmonary disease patients: fall or rise of an idea? Crit. Care Med. (1999) 27(10):2299–2301.
   Web of Science ®Google Scholar
• DUPUY PM, SHORE SA, DRAZEN JM et al.: Bronchodilator action of inhaled nitric oxide in guinea pigs. J. Clin. Invest. (1992) 90(2):421–428.
   PubMed Web of Science ®Google Scholar
• BARNES PJ: Nitric oxide and airway disease. Ann. Med. (1995) 27(3):389–393.
   PubMed Web of Science ®Google Scholar
• NIJKAMP FP, FOLKERTS G: Nitric oxide and bronchial reactivity. Clin. Exp. Allergy (1994) 24(10):905–914.
   PubMed Web of Science ®Google Scholar
• BELVISI MG, STRETTON CD, YACOUB M, BARNES PJ: Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Ear: J. Pharmacol (1992) 210(2):221–222.
   PubMed Web of Science ®Google Scholar
• ELLIS JL, UNDEM BJ: Inhibition by L-NG-nitro-L-arginine of nonadrenergic-noncholinergic-mediated relaxations of human isolated central and peripheral airway. Am. Rev Respir. Dis. (1992) 146(6):1543–1547.
   PubMed Web of Science ®Google Scholar
• HOGMAN M, WEI SZ, FROSTELL C, ARNBERG H, HEDENSTIERNA G: Effects of inhaled nitric oxide on methacholine-induced bronchoconstriction: a concentration response study in rabbits. Ear: Respir J. (1994) 7(4):698–702.
   PubMed Web of Science ®Google Scholar
• BROWN RH, ZERHOUNI EA, HIRSHMAN CA: Reversal of bronchoconstriction by inhaled nitric oxide. Histamine versus methacholine. Am. I Respir. Grit. Care Med. (1994) 150(1):233–237.
   PubMed Web of Science ®Google Scholar
• GWYN DR, LINDEMAN KS, HIRSHMAN CA: Inhaled nitric oxide attenuates bronchoconstriction in canine peripheral airways. Am. I Respir. Crit. Care Med. (1996) 153(2):604–609.
   PubMed Web of Science ®Google Scholar
• KACMAREK RM, RIPPLE R, COCKRILL BA et al.: Inhaled nitric oxide. A bronchodilator in mild asthmatics with methacholine-induced bronchospasm. Am. J. Respir. Crit. Care Med. (1996) 153(1):128–135.
   Google Scholar
• SANNA A, KURTANSKY A, VERITER C,STANESCU D: Bronchodilator effect of inhaled nitric oxide in healthy men. Am. Respir. Crit. Care Med. (1994) 150:1702–1704.
   PubMed Web of Science ®Google Scholar
• PFEFFER KD, ELLISON G, ROBERTSON D, DAY RW: The effect of inhaled nitric oxide in pediatric asthma. Am. J.Respir. Crit. Care Med. (1996) 153(2):747–751.
   PubMed Web of Science ®Google Scholar
• BARNES PJ: NO or no NO in asthma? Thorax (1996) 51(2):218–220.
   PubMed Web of Science ®Google Scholar
• WARD JK, BELVISI MG, FOX AJ et al.: Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro. I Clin. Invest (1993) 92(2):736–742.
   PubMed Web of Science ®Google Scholar
• KUO HP, LIU S, BARNES PJ: The effect of endogenous nitric oxide on neurogenic plasma exudation in guinea-pig airways. Ear: Pharmacol (1992) 221(2-3):385–388.
   PubMed Web of Science ®Google Scholar
• SANDERS SP: Nitric oxide in asthma. Pathogenic, therapeutic, or diagnostic? Am. Respir. Cell Ma Biol. (1999) 21(2):147–149.
   PubMed Web of Science ®Google Scholar
• STEUDEL W, KIRMSE M, WEIMANN J et al.: Exhaled nitric oxide production by nitric oxide synthase-deficient mice. Am. J. Respir. Crit. Care Med. (2000) 162(4):1262–1267.
   PubMed Web of Science ®Google Scholar
• XIONG Y, KARUPIAH G, HOGAN SP, FOSTER PS, RAMSAY AJ: Inhibition of allergic airway inflammation in mice lacking nitric oxide synthase 2. J. Immunol (1999) 162(1):445–452.
   PubMed Web of Science ®Google Scholar
• HIRASAKI A, JONES KA, PERKINS WJ, WARNER DO: Use of nitric oxide-nucleophile adducts as biological sources of nitric oxide: effects on airway smooth muscle. J. Pharmacol Exp. Therap. (1996) 278(3):1269–1275.
   PubMed Web of Science ®Google Scholar
• CHIDECKEL EW, FEDAN JS, MIKE P: Polyamines and putreanine relax respiratory tract smooth muscle in the guinea-pig. Ear: J. Pharmacol (1985) 116(1-2):187–190.
   PubMed Web of Science ®Google Scholar
• HESS D, BIGATELLO L, HURFORD WE: Toxicity and complications of inhaled nitric oxide. Respir. Care Clin. N Am. (1997) 3(4):487–503.
   PubMedGoogle Scholar
• GREENBAUM R, BAY J, HARGREAVESMD et al.: Effects of higher oxides of nitrogen on the anaesthetized dog. Br. J. Anaesth. (1967) 39(5):393–404.
   PubMed Web of Science ®Google Scholar
• BARTH PJ, MULLER B, WAGNER U, BITTINGER A: Quantitative analysis of parenchymal and vascular alterations in NO2-induced lung injury in rats. Ear: Respir. 1(1995) 8(7):1115–1121.
   Google Scholar
• KUBOTA K, MURAKAMI M, TAKENAKA S, KAWAI K, KYONO H: Effects of long-term nitrogen dioxide exposure on rat lung: morphological observations. Environ. Health Perspect. (1987) 73:157–69.
   PubMed Web of Science ®Google Scholar
• RADI R, BECKMAN JS, BUSH KM, FREEMAN BA: Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. I Biol. Chem. (1991) 266(7):4244–4250.
   Google Scholar
• WEINBERGER B, FAKHRZADEN L, HECK DE, LASKIN JD, GARDNER CR, LASKIN DL: Inhaled nitric oxide promes lung macrophages to produce reactive oxygen and nitrogen intermediates. Am. J. Respir. Crit. Care Med. (1998) 158:931–938.
   PubMed Web of Science ®Google Scholar
• WRIGHT RO, LEWANDER WJ, WOOLF AD: Methemoglobinemia: etiology, pharmacology, and clinical management. Ann. Emerg. Med. (1999) 34(5):646–656.
   PubMed Web of Science ®Google Scholar
• MORGAN DM, WALLACE HM: Polyamines in clinical and basic science: introductory remarks. Biochem. Soc. Trans. (1994) 22(4):845–846.
   PubMed Web of Science ®Google Scholar
• FOSTER JR, SMITH LL, HEXT PM, BRAMMER A, SOAMES AR, VVYATT I: Target cell toxicity of inhaled spermidine in rat lungs. Int. J. Exp. Pathol (1990) 71(5):617–630.
   PubMed Web of Science ®Google Scholar
• LEUNG HW, VAN MILLER JP: Effects of diethylenetriamine dihydrochloride following 13 weeks of dietary dosing in Fischer 344 rats. Food Chem. Toxicol. (1997) 35(5):481–487.
   PubMed Web of Science ®Google Scholar